When are bispecific antibodies and CAR T-cell therapy used for DLBCL, and how might that change in the future?

When are bispecific antibodies and CAR T-cell therapy used for DLBCL, and how might that change in the future?
What treatments are available for patients with relapsed refractory myeloma who have received at least two prior lines of therapy but less than 4 lines of therapy?
What is the difference between phenotype and genotype?
BETA - What is the role of the care partner once the patient returns home?
BETA - What are the main side effects of CAR T-cell therapy?
BETA - Would I need to get a central line, PICC line or a catheter for CAR T-cell treatment?
What is a gene? What is an allele? What is a genetic trait?
What types of dental work and safely be done during induction therapy
Do patients who have myelodysplastic syndromes progress to acute myeloid leukemia all have the same type of acute myeloid leukemia?
The Specifics of Estate Planning